Home » Topics » BioWorld Science

BioWorld Science
RSS

Targeting specific behavioral immune traits of inflammation

Jan. 20, 2022

DNA-PK activates survival kinase AKT in response to DNA damage

Jan. 20, 2022

Red Bull GmbH presents dopamine reuptake inhibitors

Jan. 20, 2022

Medshine Discovery synthesizes new JAK3 inhibitors

Jan. 20, 2022

Sun Pharmaceutical Industries divulges GIPR and GLP-1 receptor dual agonists

Jan. 20, 2022

Jiangsu Hengrui Medicine and Shanghai Hengrui Pharmaceutical patent new ATR kinase inhibitors

Jan. 20, 2022

Kallyope presents new AMPK activators

Jan. 20, 2022

Nanodecoys scavenge RANKL and TNF-alpha for osteoporosis treatment

Jan. 20, 2022

Targeting DICAM impedes migration of disease-inducing leukocytes into the CNS in multiple sclerosis

Jan. 20, 2022

Oncostatin M blockade ameliorates severe asthma

Jan. 20, 2022

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...